Package 60687-216-25

Brand: entecavir

Generic: entecavir
NDC Package

Package Facts

Identity

Package NDC 60687-216-25
Digits Only 6068721625
Product NDC 60687-216
Product ID 60687-216_1fbb7ecd-d5f8-a13d-e063-6294a90afc16
Description

30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-216-25) / 1 TABLET in 1 BLISTER PACK (60687-216-95)

Marketing

Marketing Status
Marketed Since 2016-08-12
Brand entecavir
Generic entecavir
Sample Package No

Linked Drug Pages (1)

Entecavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1fbb7ecd-d5f8-a13d-e063-6294a90afc16", "openfda": {"unii": ["5968Y6H45M"], "rxcui": ["485434"], "spl_set_id": ["a0d2e00d-21f0-4449-93b7-a19fa284d51d"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-216-25)  / 1 TABLET in 1 BLISTER PACK (60687-216-95)", "package_ndc": "60687-216-25", "marketing_start_date": "20160812"}], "brand_name": "Entecavir", "product_id": "60687-216_1fbb7ecd-d5f8-a13d-e063-6294a90afc16", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "60687-216", "generic_name": "Entecavir", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Entecavir", "active_ingredients": [{"name": "ENTECAVIR", "strength": ".5 mg/1"}], "application_number": "ANDA206217", "marketing_category": "ANDA", "marketing_start_date": "20160812", "listing_expiration_date": "20261231"}